Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Uk Mhra Gmp
  6. /
  7. MACFARLAN SMITH LIMITED
Uk Mhra Gmp
•MACFARLAN SMITH LIMITED•December 19, 2024

MACFARLAN SMITH LIMITED – UK MHRA GMP Certificate UK API 1108 Insp GMP/GDP 1108/1893-0019

Record Details

This Uk Mhra Gmp record concerns MACFARLAN SMITH LIMITED, with an inspection on December 19, 2024, issued by the MHRA, covering drugs.

Company
MACFARLAN SMITH LIMITED
Compliance status
GMPC
Certificate type
GMP
Inspection date
December 19, 2024
Issued
December 19, 2024
MIA number
UK API 1108
Site address
10 WHEATFIELD ROAD, EDINBURGH, EH11 2QA, UNITED KINGDOM
Country
UNITED KINGDOM
Products
Human Medicinal Products
Manufacturing operations
[2000007584] FENTANYL CITRATE [2000015376] CODEINE SULFATE [2000006818] SUFENTANIL CITRATE [2000007868] HYDROMORPHONE HYDROCHLORIDE [1000007438] OXYCODONE [2000008247] MORPHINE HYDROCHLORIDE [2000008051] APOMORPHINE HYDROCHLORIDE [2000008305] METHYLPHENIDATE HYDROCHLORIDE [1000003943] COCAINE [2000007776] DIAMORPHINE HYDROCHLORIDE [2000007435] REMIFENTANIL HYDROCHLORIDE [2000008238] NALOXONE HYDROCHLORIDE [2000008277] BUPRENORPHINE HYDROCHLORIDE [4000006163] MORPHINE SULFATE [1000003221] DIAMORPHINE [2000008540] ALFENTANIL HYDROCHLORIDE [1000002290] FENTANYL [4000008052] DIHYDROCODEINE HYDROGEN TARTRATE [2000007943] COCAINE HYDROCHLORIDE [1000003912] CODEINE [1000010779] MORPHINE [2000008245] MORPHINE TARTRATE [4000006570] CODEINE PHOSPHATE HEMIHYDRATE [1000007171] BUPRENORPHINE [2000006722] OXYCODONE HYDROCHLORIDE [1000009886] PHOLCODINE Active Substances 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES FENTANYL CITRATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) CODEINE SULFATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing SUFENTANIL CITRATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Sieving 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) HYDROMORPHONE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) OXYCODONE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Crytsallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying and milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing MORPHINE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) APOMORPHINE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt Formation, Filtration, Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) METHYLPHENIDATE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing COCAINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing DIAMORPHINE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt Formation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) REMIFENTANIL HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt Formation, Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Sieving 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) NALOXONE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) BUPRENORPHINE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt Formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) MORPHINE SULFATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) DIAMORPHINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing ALFENTANIL HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt Formation, Filtration, Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Sieving 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) FENTANYL 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Recrystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing DIHYDROCODEINE HYDROGEN TARTRATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing COCAINE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing CODEINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying and milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing MORPHINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing MORPHINE TARTRATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing CODEINE PHOSPHATE HEMIHYDRATE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing BUPRENORPHINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing OXYCODONE HYDROCHLORIDE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Salt formation, Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing 3.6.2  Microbiological testing (excluding sterility testing) PHOLCODINE 3.1 Manufacture of Active Substance by Chemical Synthesis 3.1.1  Manufacture Of Active Substance Intermediates 3.1.2  Manufacture Of Crude Active Substance 3.1.3  Salt Formation/Purification steps (eg. Crystallisation) Crystallisation 3.5 General Finishing Steps 3.5.1  Physical Processing Steps Drying, Milling 3.5.2  Primary Packaging 3.5.3  Secondary Packaging 3.6 Quality Control Testing 3.6.1  Physical / Chemical testing
Restrictions
This certificate is issued based on a desk-based assessment of GMP compliance information provided by the manufacturer. This certificate should be used in combination with the relevant authorisation/registration. A risk-based site inspection programme remains in force.
View Company Profile

ID · 092e1f7f-428a-468d-8274-3b4029ea197a

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MACFARLAN SMITH LIMITED
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.